Expertise in
28
conditions

Dr. Ying J. Hitchcock

Radiation Oncology
Radiation Oncology - Sugarhouse
1280 E Stringham Ave, 
Salt Lake City, UT 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
28
conditions
Radiation Oncology - Sugarhouse
1280 E Stringham Ave, 
Salt Lake City, UT 

Overview

Ying Hitchcock is a Radiation Oncologist practicing medicine in Salt Lake City, Utah.

Dr. Hitchcock is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Tongue Cancer, Adult Soft Tissue Sarcoma, Angiosarcoma of the Scalp, and Lung Cancer.

Dr. Hitchcock is board certified in American Board Of Radiology. She is actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 7 clinical trials. Dr. Hitchcock is currently accepting new patients.

Graduate Institution

Peking Union Medical College

Specialties

Radiation Oncology

Licenses

Radiology in UT

Board Certifications

American Board Of Radiology

Hospital Affiliations

University Of Utah Hospital And Clinics

Languages Spoken

English
Mandarin

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Regence
  • EPO
  • PPO
SelectHealth
  • HMO
  • POS
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Radiation Oncology - Sugarhouse
1280 E Stringham Ave, Salt Lake City, UT 84106
Other Locations
Huntsman Cancer Institute Rad. Onc.
1950 Circle Of Hope Dr, Salt Lake City, UT 84112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Enrollment Status: Suspended
Publish Date: September 01, 2026
Intervention Type: Procedure, Drug, Other, Radiation, Biological
Study Drugs: Atezolizumab, Cetuximab, Cisplatin, Docetaxel
Study Phase: Phase 2/Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
Enrollment Status: Completed
Publish Date: June 17, 2026
Intervention Type: Drug, Radiation, Procedure
Study Drugs: Doxorubicin, Ifosfamide, Pazopanib
Study Phase: Phase 2/Phase 3
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
Enrollment Status: Completed
Publish Date: May 22, 2026
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Completed
Publish Date: June 10, 2022
Intervention Type: Drug, Other, Radiation, Biological
Study Drugs: Cisplatin, Pembrolizumab
Study Phase: Phase 1
View 6 Less Clinical Trials

63 Total Publications

Phase 1 trial of pre-operative image guided intensity modulated photon radiotherapy with simultaneously integrated boost to the high-risk margin for patients with retroperitoneal sarcoma.
Phase 1 trial of pre-operative image guided intensity modulated photon radiotherapy with simultaneously integrated boost to the high-risk margin for patients with retroperitoneal sarcoma.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 04, 2026
Similar Doctors
Expertise in
10
conditions
Dr. David K. Gaffney
Radiation Oncology
Expertise in
10
conditions
Dr. David K. Gaffney
Radiation Oncology
Referral may be required

Radiation Oncology - Sugarhouse

1280 E Stringham Ave, 
Salt Lake City, UT 
 (0.1 miles away)
801-581-2396
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Gaffney is a Radiation Oncologist practicing medicine in Salt Lake City, Utah. Dr. Gaffney is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Endometrial Cancer, Vulvar Cancer, and Breast Cancer. Dr. Gaffney is board certified in American Board Of Radiology. Dr. Gaffney is currently accepting new patients.

Expertise in
6
conditions
Dr. Jonathan D. Tward
Radiation Oncology
Expertise in
6
conditions
Dr. Jonathan D. Tward
Radiation Oncology
Referral may be required

Radiation Oncology - Sugarhouse

1280 E Stringham Ave, 
Salt Lake City, UT 
 (0.1 miles away)
801-581-2396
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathan Tward is a Radiation Oncologist practicing medicine in Salt Lake City, Utah. Dr. Tward is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Prostatectomy, and Reconstructive Urology Surgery. Dr. Tward is board certified in American Board Of Radiology. Dr. Tward is currently accepting new patients.

Expertise in
8
conditions
Dr. Dennis C. Shrieve
Radiation Oncology
Expertise in
8
conditions
Dr. Dennis C. Shrieve
Radiation Oncology
Referral may be required

Radiation Oncology - Sugarhouse

1280 E Stringham Ave, 
Salt Lake City, UT 
 (0.1 miles away)
801-581-2396
Languages Spoken:
English
Accepting New Patients

Dennis Shrieve is a Radiation Oncologist practicing medicine in Salt Lake City, Utah. Dr. Shrieve is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Meningioma, Radiation Induced Meningioma, Gliosarcoma, Prostatectomy, and Microvascular Decompression. Dr. Shrieve is board certified in American Board Of Radiology. Dr. Shrieve is currently accepting new patients.

Frequently Asked Questions about Dr. Ying J. Hitchcock

How do I make an appointment with Dr. Ying J. Hitchcock?

You can book an appointment with Dr. Ying J. Hitchcock by calling their office at 801-581-2396. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ying J. Hitchcock a top-rated expert for Tongue Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ying J. Hitchcock is classified as an Distinguished expert for Tongue Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ying J. Hitchcock specialize in?

While Dr. Ying J. Hitchcock is a Radiation Oncology, they have specific expertise in Tongue Cancer, Adult Soft Tissue Sarcoma, and Angiosarcoma of the Scalp. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Ying J. Hitchcock participate in research or clinical trials?

Yes. Dr. Ying J. Hitchcock has published 63 articles and abstracts on conditions like Tongue Cancer. You can view a list of Dr. Ying J. Hitchcock's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ying J. Hitchcock accept my insurance?

Dr. Ying J. Hitchcock accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 801-581-2396 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hitchcock's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 20 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile